The most exciting treatment for inherited retinal disease was approved in 2017, but there are many novel treatments in phase 2 or phase 3 trials at this point, said Byron L. Lam, MD, professor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results